StockNews.com upgraded shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) from a hold rating to a buy rating in a research note released on Tuesday.
Separately, HC Wainwright upped their price objective on Dynavax Technologies from $29.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday.
Get Our Latest Stock Report on Dynavax Technologies
Dynavax Technologies Stock Performance
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC grew its stake in Dynavax Technologies by 175.5% in the 3rd quarter. GAMMA Investing LLC now owns 2,645 shares of the biopharmaceutical company’s stock valued at $29,000 after purchasing an additional 1,685 shares during the period. US Bancorp DE grew its stake in Dynavax Technologies by 291.4% in the 3rd quarter. US Bancorp DE now owns 2,732 shares of the biopharmaceutical company’s stock valued at $30,000 after purchasing an additional 2,034 shares during the period. Capital Performance Advisors LLP bought a new position in shares of Dynavax Technologies during the 3rd quarter worth $45,000. Nisa Investment Advisors LLC grew its stake in shares of Dynavax Technologies by 44.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 5,441 shares of the biopharmaceutical company’s stock worth $61,000 after acquiring an additional 1,679 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Dynavax Technologies during the 3rd quarter worth $89,000. Institutional investors own 96.96% of the company’s stock.
Dynavax Technologies Company Profile
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.
Featured Articles
- Five stocks we like better than Dynavax Technologies
- How to Read Stock Charts for Beginners
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- 3 Healthcare Dividend Stocks to Buy
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- How to invest in marijuana stocks in 7 stepsĀ
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Dynavax Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynavax Technologies and related companies with MarketBeat.com's FREE daily email newsletter.